US4942184A
(en)
*
|
1988-03-07 |
1990-07-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water soluble, antineoplastic derivatives of taxol
|
FR2629819B1
(fr)
*
|
1988-04-06 |
1990-11-16 |
Rhone Poulenc Sante |
Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
|
USRE34277E
(en)
*
|
1988-04-06 |
1993-06-08 |
Centre National De La Recherche Scientifique |
Process for preparing taxol
|
FR2629818B1
(fr)
*
|
1988-04-06 |
1990-11-16 |
Centre Nat Rech Scient |
Procede de preparation du taxol
|
US4960790A
(en)
*
|
1989-03-09 |
1990-10-02 |
University Of Kansas |
Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
|
US5175315A
(en)
*
|
1989-05-31 |
1992-12-29 |
Florida State University |
Method for preparation of taxol using β-lactam
|
MY110249A
(en)
*
|
1989-05-31 |
1998-03-31 |
Univ Florida State |
Method for preparation of taxol using beta lactam
|
FR2651226B1
(fr)
*
|
1989-08-23 |
1993-01-08 |
Centre Nat Rech Scient |
Procede pour la preparation enantioselective de derives de la phenylisoserine.
|
IL95436A
(en)
*
|
1989-08-23 |
1996-07-23 |
Centre Nat Rech Scient |
Process for preparing the history of phenylisosarine
|
US5304670A
(en)
*
|
1989-08-23 |
1994-04-19 |
Centre National De La Recherche Scientifique |
Process for the enantioselective preparation of phenylisoserine derivatives
|
US5015744A
(en)
*
|
1989-11-14 |
1991-05-14 |
Florida State University |
Method for preparation of taxol using an oxazinone
|
US5136060A
(en)
*
|
1989-11-14 |
1992-08-04 |
Florida State University |
Method for preparation of taxol using an oxazinone
|
FR2658513B1
(fr)
*
|
1990-02-21 |
1994-02-04 |
Rhone Poulenc Sante |
Procede de preparation de l'acide cis-beta-phenylglycidique-(2r,3r).
|
FR2662441B1
(fr)
*
|
1990-05-22 |
1992-10-23 |
Rhone Poulenc Sante |
Procede de preparation enantioselective de derives de la phenylisoserine.
|
FR2662440B1
(fr)
*
|
1990-05-22 |
1992-07-31 |
Rhone Poulenc Sante |
Procede de preparation stereoselective de derives de la phenylisoserine.
|
US5059699A
(en)
*
|
1990-08-28 |
1991-10-22 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble derivatives of taxol
|
US5380916A
(en)
*
|
1990-11-02 |
1995-01-10 |
University Of Florida |
Method for the isolation and purification of taxane derivatives
|
US5475120A
(en)
*
|
1990-11-02 |
1995-12-12 |
University Of Florida |
Method for the isolation and purification of taxol and its natural analogues
|
FR2669631B1
(fr)
*
|
1990-11-23 |
1994-09-09 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de l'oxazolidine, leur preparation et leur emploi.
|
EP0580759B1
(en)
*
|
1991-04-19 |
1999-05-26 |
The University Of Mississippi |
Methods and compositions for isolating taxanes
|
US6150398A
(en)
*
|
1991-05-08 |
2000-11-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods for the treatment of cancer
|
CA2072400C
(en)
|
1991-07-05 |
2003-08-19 |
Jayaprakash B. Nair |
Supercritical extraction of taxanes
|
FR2678833B1
(fr)
*
|
1991-07-08 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
|
US5698582A
(en)
*
|
1991-07-08 |
1997-12-16 |
Rhone-Poulenc Rorer S.A. |
Compositions containing taxane derivatives
|
US5750561A
(en)
*
|
1991-07-08 |
1998-05-12 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
FR2678930B1
(fr)
*
|
1991-07-10 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
|
FR2679230B1
(fr)
*
|
1991-07-16 |
1993-11-19 |
Rhone Poulenc Rorer Sa |
Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
|
US6335362B1
(en)
|
1991-09-23 |
2002-01-01 |
Florida State University |
Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
|
US6028205A
(en)
*
|
1991-09-23 |
2000-02-22 |
Florida State University |
C2 tricyclic taxanes
|
US5990325A
(en)
|
1993-03-05 |
1999-11-23 |
Florida State University |
Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
|
US6005138A
(en)
*
|
1991-09-23 |
1999-12-21 |
Florida State University |
Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
|
US5284864A
(en)
*
|
1991-09-23 |
1994-02-08 |
Florida State University |
Butenyl substituted taxanes and pharmaceutical compositions containing them
|
US5710287A
(en)
*
|
1991-09-23 |
1998-01-20 |
Florida State University |
Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
|
US5227400A
(en)
*
|
1991-09-23 |
1993-07-13 |
Florida State University |
Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
|
US5739362A
(en)
*
|
1991-09-23 |
1998-04-14 |
Florida State University |
Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
|
US5489601A
(en)
*
|
1991-09-23 |
1996-02-06 |
Florida State University |
Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
|
US5998656A
(en)
*
|
1991-09-23 |
1999-12-07 |
Florida State University |
C10 tricyclic taxanes
|
US6018073A
(en)
*
|
1991-09-23 |
2000-01-25 |
Florida State University |
Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
|
US5399726A
(en)
*
|
1993-01-29 |
1995-03-21 |
Florida State University |
Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
|
US5229526A
(en)
*
|
1991-09-23 |
1993-07-20 |
Florida State University |
Metal alkoxides
|
US5283253A
(en)
*
|
1991-09-23 |
1994-02-01 |
Florida State University |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
|
SG46582A1
(en)
*
|
1991-09-23 |
1998-02-20 |
Univ Florida State |
10-Desacetoxytaxol derivatives
|
US5721268A
(en)
*
|
1991-09-23 |
1998-02-24 |
Florida State University |
C7 taxane derivatives and pharmaceutical compositions containing them
|
US5430160A
(en)
*
|
1991-09-23 |
1995-07-04 |
Florida State University |
Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
|
US5250683A
(en)
*
|
1991-09-23 |
1993-10-05 |
Florida State University |
Certain substituted taxanes and pharmaceutical compositions containing them
|
US5274124A
(en)
*
|
1991-09-23 |
1993-12-28 |
Florida State University |
Metal alkoxides
|
US7074945B2
(en)
*
|
1991-09-23 |
2006-07-11 |
Florida State University |
Metal alkoxide taxane derivatives
|
US5728850A
(en)
*
|
1991-09-23 |
1998-03-17 |
Florida State University |
Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
|
US5728725A
(en)
*
|
1991-09-23 |
1998-03-17 |
Florida State University |
C2 taxane derivaties and pharmaceutical compositions containing them
|
US5714513A
(en)
*
|
1991-09-23 |
1998-02-03 |
Florida State University |
C10 taxane derivatives and pharmaceutical compositions
|
US6794523B2
(en)
|
1991-09-23 |
2004-09-21 |
Florida State University |
Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
|
US6495704B1
(en)
|
1991-09-23 |
2002-12-17 |
Florida State University |
9-desoxotaxanes and process for the preparation of 9-desoxotaxanes
|
US5654447A
(en)
*
|
1991-09-23 |
1997-08-05 |
Florida State University |
Process for the preparation of 10-desacetoxybaccatin III
|
US5243045A
(en)
*
|
1991-09-23 |
1993-09-07 |
Florida State University |
Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
|
US6011056A
(en)
|
1991-09-23 |
2000-01-04 |
Florida State University |
C9 taxane derivatives and pharmaceutical compositions containing them
|
DE69329304T2
(de)
*
|
1992-01-15 |
2001-01-04 |
E.R. Squibb & Sons, Inc. |
Enzymatische Verfahren zur Resolution von Enantiomeren-Mischungen nützlich wie Zwischenprodukte zur Herstellung von Taxanen
|
US6080777A
(en)
*
|
1992-01-31 |
2000-06-27 |
The Trustees Of Columbia University In The City Of New York |
Taxol as a radiation sensitizer
|
EP0624096A4
(en)
*
|
1992-01-31 |
1995-04-19 |
Univ Columbia |
TAXOL AS A SENSITIZER FOR RADIATION.
|
US5272171A
(en)
*
|
1992-02-13 |
1993-12-21 |
Bristol-Myers Squibb Company |
Phosphonooxy and carbonate derivatives of taxol
|
US5294737A
(en)
*
|
1992-02-27 |
1994-03-15 |
The Research Foundation State University Of New York |
Process for the production of chiral hydroxy-β-lactams and hydroxyamino acids derived therefrom
|
US5445809A
(en)
*
|
1992-03-03 |
1995-08-29 |
Research And Development Institute At Montana State University |
Production of taxol from the yew tree
|
US5451392A
(en)
*
|
1992-03-03 |
1995-09-19 |
The Research And Development Institute At Montana State University |
Production of taxol
|
FR2688518B1
(fr)
*
|
1992-03-13 |
1994-05-06 |
Rhone Poulenc Rorer Sa |
Procede de preparation de derives du taxane.
|
US5200534A
(en)
*
|
1992-03-13 |
1993-04-06 |
University Of Florida |
Process for the preparation of taxol and 10-deacetyltaxol
|
US5254703A
(en)
*
|
1992-04-06 |
1993-10-19 |
Florida State University |
Semi-synthesis of taxane derivatives using metal alkoxides and oxazinones
|
US5322779A
(en)
*
|
1992-04-16 |
1994-06-21 |
The Research And Development Institute, Inc. At Montana State University |
Taxol production by taxomyces andreanae
|
CA2130578A1
(en)
*
|
1992-04-17 |
1993-10-28 |
Geewananda P. Gunawardana |
Taxol derivatives
|
JPH069600A
(ja)
*
|
1992-05-06 |
1994-01-18 |
Bristol Myers Squibb Co |
タクソールのベンゾエート誘導体
|
FR2691460B1
(fr)
*
|
1992-05-21 |
1994-07-22 |
Rhone Poulenc Rorer Sa |
Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent.
|
US5284944A
(en)
*
|
1992-06-30 |
1994-02-08 |
Lever Brothers Company, Division Of Conopco, Inc. |
Improved synthesis of 1,4,7-triazacyclononane
|
US5254580A
(en)
*
|
1993-01-19 |
1993-10-19 |
Bristol-Myers Squibb Company |
7,8-cyclopropataxanes
|
US5294637A
(en)
*
|
1992-07-01 |
1994-03-15 |
Bristol-Myers Squibb Company |
Fluoro taxols
|
US5364947A
(en)
*
|
1992-07-02 |
1994-11-15 |
Hauser Chemical Research, Inc. |
Process for separating cephalomannine from taxol using ozone and water-soluble hydrazines or hydrazides
|
FR2693193B1
(fr)
*
|
1992-07-03 |
1994-09-02 |
Rhone Poulenc Rorer Sa |
Nouveaux dérivés de la désacétyl-10 baccatine III, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
CA2086874E
(en)
*
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
US5319112A
(en)
*
|
1992-08-18 |
1994-06-07 |
Virgnia Tech Intellectual Properties, Inc. |
Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
|
US5470866A
(en)
*
|
1992-08-18 |
1995-11-28 |
Virginia Polytechnic Institute And State University |
Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
|
US5614549A
(en)
*
|
1992-08-21 |
1997-03-25 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
US5789189A
(en)
*
|
1993-09-24 |
1998-08-04 |
The Regents Of The University Of California |
Inhibition of cyst formation by cytoskeletal specific drugs
|
FR2696462B1
(fr)
*
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé d'obtention de la désacétyl-10 baccatine III.
|
FR2696459B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
FR2696461B1
(fr)
*
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent.
|
FR2696460B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
FR2696463B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé d'obtention de la désacétyl-10 baccatine III.
|
US5411984A
(en)
*
|
1992-10-16 |
1995-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble analogs and prodrugs of taxol
|
FR2697752B1
(fr)
*
|
1992-11-10 |
1995-04-14 |
Rhone Poulenc Rorer Sa |
Compositions antitumorales contenant des dérivés du taxane.
|
US5420337A
(en)
*
|
1992-11-12 |
1995-05-30 |
E. R. Squibb & Sons, Inc. |
Enzymatic reduction method for the preparation of compounds useful for preparing taxanes
|
FR2697841B1
(fr)
*
|
1992-11-12 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
FR2698363B1
(fr)
*
|
1992-11-23 |
1994-12-30 |
Rhone Poulenc Rorer Sa |
Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent.
|
ES2119996T3
(es)
*
|
1992-11-27 |
1998-10-16 |
Napro Biotherapeutics Inc |
Composicion inyectable que comprende faclitaxel.
|
AU5553894A
(en)
*
|
1992-11-27 |
1994-06-22 |
F.H. Faulding & Co. Limited |
Injectable taxol composition
|
FR2698629B1
(fr)
*
|
1992-12-02 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
US5356927A
(en)
*
|
1992-12-02 |
1994-10-18 |
Thomas Jefferson University |
Methods of treating plasmodium and babesia parasitic infections
|
FR2698543B1
(fr)
*
|
1992-12-02 |
1994-12-30 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions à base de taxoides.
|
US5631278A
(en)
*
|
1992-12-02 |
1997-05-20 |
Thomas Jefferson University |
Methods of killing protozoal parasites
|
US5380751A
(en)
*
|
1992-12-04 |
1995-01-10 |
Bristol-Myers Squibb Company |
6,7-modified paclitaxels
|
CA2109861C
(en)
*
|
1992-12-04 |
1999-03-16 |
Shu-Hui Chen |
6,7-modified paclitaxels
|
FR2698871B1
(fr)
*
|
1992-12-09 |
1995-02-24 |
Rhone Poulenc Rorer Sa |
Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
IL107950A
(en)
|
1992-12-15 |
2001-04-30 |
Upjohn Co |
b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
|
US5973160A
(en)
*
|
1992-12-23 |
1999-10-26 |
Poss; Michael A. |
Methods for the preparation of novel sidechain-bearing taxanes
|
US5646176A
(en)
*
|
1992-12-24 |
1997-07-08 |
Bristol-Myers Squibb Company |
Phosphonooxymethyl ethers of taxane derivatives
|
US5688517A
(en)
*
|
1993-01-29 |
1997-11-18 |
Napro Biotherapeutics, Inc. |
Method for assessing sensitivity of tumor cells to cephalomannine and 10-deacetyltaxol
|
BR9405687C1
(pt)
*
|
1993-02-05 |
2001-08-07 |
Bryn Mawr College |
Processo quìmico utilizável na produção de análogos de taxol e, composto quìmico
|
FR2702212B1
(fr)
*
|
1993-03-02 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
US6710191B2
(en)
|
1993-03-05 |
2004-03-23 |
Florida State University |
9β-hydroxytetracyclic taxanes
|
DE69432140T2
(de)
*
|
1993-03-05 |
2003-07-31 |
Florida State University, Tallahassee |
Verfahren zur Herstellung von 9-Desoxotaxanen
|
WO1994020453A1
(en)
*
|
1993-03-09 |
1994-09-15 |
Enzon, Inc. |
Taxol polyalkylene oxide conjugates of taxol and taxol intermediates
|
US5547981A
(en)
*
|
1993-03-09 |
1996-08-20 |
Enzon, Inc. |
Taxol-7-carbazates
|
US5703247A
(en)
*
|
1993-03-11 |
1997-12-30 |
Virginia Tech Intellectual Properties, Inc. |
2-Debenzoyl-2-acyl taxol derivatives and methods for making same
|
TW467896B
(en)
|
1993-03-19 |
2001-12-11 |
Bristol Myers Squibb Co |
Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
|
FR2703049B1
(fr)
*
|
1993-03-22 |
1995-04-21 |
Rhone Poulenc Rorer Sa |
Procédé de purification des taxoïdes.
|
DE69434374T2
(de)
*
|
1993-03-22 |
2005-11-24 |
Florida State University, Tallahassee |
Taxane mit Furyl oder Thienyl enthaltender substituierter Seitenkette
|
US5336684A
(en)
*
|
1993-04-26 |
1994-08-09 |
Hauser Chemical Research, Inc. |
Oxidation products of cephalomannine
|
PT982302E
(pt)
*
|
1993-06-11 |
2004-07-30 |
Upjohn Co |
Utilizacao de delta 6,7-taxois antineoplasicos e composicoes farmaceuticas que os contem
|
FR2707165B1
(fr)
*
|
1993-07-06 |
1995-08-11 |
Rhone Poulenc Rorer Sa |
Application des taxoides au traitement de maladies d'origine parasitaire .
|
US6005120A
(en)
*
|
1993-07-20 |
1999-12-21 |
Florida State University |
Tricyclic and tetracyclic taxanes
|
US5405972A
(en)
*
|
1993-07-20 |
1995-04-11 |
Florida State University |
Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
|
US5880131A
(en)
*
|
1993-10-20 |
1999-03-09 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
US5965566A
(en)
*
|
1993-10-20 |
1999-10-12 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
CA2174350A1
(en)
*
|
1993-10-20 |
1995-04-27 |
Richard B. Greenwald |
2'- and/or 7- substituted taxoids
|
US6441026B1
(en)
|
1993-11-08 |
2002-08-27 |
Aventis Pharma S.A. |
Antitumor compositions containing taxane derivatives
|
US5415869A
(en)
*
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
IL112412A
(en)
*
|
1994-01-28 |
2000-02-29 |
Upjohn Co |
Delta 12,13-iso-taxol analogs and antineoplastic pharmaceutical compositions containing them
|
GB9405400D0
(en)
*
|
1994-03-18 |
1994-05-04 |
Erba Carlo Spa |
Taxane derivatives
|
DE4416374A1
(de)
*
|
1994-05-05 |
1995-11-09 |
Schering Ag |
Neue Borneolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
US5508447A
(en)
*
|
1994-05-24 |
1996-04-16 |
Board Of Regents, The University Of Texas System |
Short synthetic route to taxol and taxol derivatives
|
US5602272A
(en)
*
|
1994-06-21 |
1997-02-11 |
Bristol-Myers Squibb Company |
Reduction and resolution methods for the preparation of compounds useful as intemediates for preparing taxanes
|
US5677470A
(en)
|
1994-06-28 |
1997-10-14 |
Tanabe Seiyaku Co., Ltd. |
Baccatin derivatives and processes for preparing the same
|
FR2722191B1
(fr)
*
|
1994-07-08 |
1996-08-23 |
Rhone Poulenc Rorer Sa |
Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
|
FR2723094A1
(fr)
*
|
1994-07-26 |
1996-02-02 |
Rhone Poulenc Rorer Sa |
Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
|
US6201140B1
(en)
|
1994-07-28 |
2001-03-13 |
Bristol-Myers Squibb Company |
7-0-ethers of taxane derivatives
|
CA2163837C
(en)
†
|
1994-12-13 |
1999-07-20 |
Robert K. Perrone |
Crystalline paclitaxel hydrates
|
EP0793499B1
(en)
*
|
1994-12-15 |
2005-10-19 |
Baker Norton Pharmaceuticals, Inc. |
Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
|
CA2170661A1
(en)
|
1995-03-22 |
1996-09-23 |
John K. Thottathil |
Novel methods for the preparation of taxanes using oaxzolidine intermediates
|
US5840929A
(en)
*
|
1995-04-14 |
1998-11-24 |
Bristol-Myers Squibb Company |
C4 methoxy ether derivatives of paclitaxel
|
CA2178541C
(en)
*
|
1995-06-07 |
2009-11-24 |
Neal E. Fearnot |
Implantable medical device
|
US5807888A
(en)
*
|
1995-12-13 |
1998-09-15 |
Xechem International, Inc. |
Preparation of brominated paclitaxel analogues and their use as effective antitumor agents
|
US6177456B1
(en)
|
1995-10-02 |
2001-01-23 |
Xechem International, Inc. |
Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor
|
US5840748A
(en)
*
|
1995-10-02 |
1998-11-24 |
Xechem International, Inc. |
Dihalocephalomannine and methods of use therefor
|
US5854278A
(en)
*
|
1995-12-13 |
1998-12-29 |
Xechem International, Inc. |
Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
|
US5654448A
(en)
*
|
1995-10-02 |
1997-08-05 |
Xechem International, Inc. |
Isolation and purification of paclitaxel from organic matter containing paclitaxel, cephalomannine and other related taxanes
|
WO1997023208A1
(en)
*
|
1995-12-21 |
1997-07-03 |
Genelabs Technologies, Inc. |
Taxane composition and method
|
FR2743074B1
(fr)
*
|
1995-12-27 |
1998-03-27 |
Seripharm |
Procede de protection selective des derives de la baccatine et son utilisation dans la synthese des taxanes
|
US6107497A
(en)
*
|
1996-02-29 |
2000-08-22 |
Napro Biotherapeutics, Inc. |
Intermediate for use in docetaxel synthesis and production method therefor
|
US5688977A
(en)
*
|
1996-02-29 |
1997-11-18 |
Napro Biotherapeutics, Inc. |
Method for docetaxel synthesis
|
AU724499B2
(en)
|
1996-05-06 |
2000-09-21 |
Florida State University |
1-deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
|
DE69715417T2
(de)
|
1996-05-08 |
2003-06-05 |
Pharmacia & Upjohn Co., Kalamazoo |
Oxazolidinester
|
IT1283633B1
(it)
*
|
1996-05-10 |
1998-04-23 |
Indena Spa |
Derivati tassanici loro sintesi e formulazioni che li contengono
|
US6576636B2
(en)
*
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
US5919815A
(en)
*
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
WO1997044026A1
(en)
*
|
1996-05-22 |
1997-11-27 |
Neuromedica, Inc. |
Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
DE69734060T2
(de)
|
1996-05-24 |
2006-06-29 |
Angiotech Pharmaceuticals, Inc., Vancouver |
Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
|
US5635531A
(en)
*
|
1996-07-08 |
1997-06-03 |
Bristol-Myers Squibb Company |
3'-aminocarbonyloxy paclitaxels
|
US5750737A
(en)
*
|
1996-09-25 |
1998-05-12 |
Sisti; Nicholas J. |
Method for paclitaxel synthesis
|
US5773464A
(en)
*
|
1996-09-30 |
1998-06-30 |
Bristol-Myers Squibb Company |
C-10 epoxy taxanes
|
US5977386A
(en)
*
|
1996-12-24 |
1999-11-02 |
Bristol-Myers Squibb Company |
6-thio-substituted paclitaxels
|
US5902822A
(en)
*
|
1997-02-28 |
1999-05-11 |
Bristol-Myers Squibb Company |
7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
|
US5912264A
(en)
*
|
1997-03-03 |
1999-06-15 |
Bristol-Myers Squibb Company |
6-halo-or nitrate-substituted paclitaxels
|
US6017935A
(en)
*
|
1997-04-24 |
2000-01-25 |
Bristol-Myers Squibb Company |
7-sulfur substituted paclitaxels
|
CA2288306A1
(en)
*
|
1997-04-28 |
1998-11-05 |
Rhone-Poulenc Rorer S.A. |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
BE1011216A3
(fr)
*
|
1997-06-13 |
1999-06-01 |
Thissen En Abrege L T B Lab |
Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
|
US6545125B1
(en)
*
|
1997-11-18 |
2003-04-08 |
Chugai Seiyaku Kabushiki Kaisha |
Compounds with antitumor activity
|
US5917062A
(en)
*
|
1997-11-21 |
1999-06-29 |
Indena S.P.A |
Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
|
US6235782B1
(en)
|
1998-11-12 |
2001-05-22 |
Rifat Pamukcu |
Method for treating a patient with neoplasia by treatment with a platinum coordination complex
|
US6235776B1
(en)
*
|
1998-11-12 |
2001-05-22 |
Cell Pathways, Inc. |
Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
|
US7235583B1
(en)
*
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
FR2794771B1
(fr)
*
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
GB9920548D0
(en)
*
|
1999-08-31 |
1999-11-03 |
Rhone Poulenc Rorer Sa |
Treatment of hepatocellular carcinoma
|
CA2385528C
(en)
|
1999-10-01 |
2013-12-10 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
DE60016625T2
(de)
*
|
1999-11-09 |
2005-12-22 |
Societe De Conseils De Recherches Et D'applications Scientifiques(S.C.R.A.S.) |
Zusammensetzung enthaltend einen inhibitor der signaltransduktion von heterotrimerischen g-proteinen in kombination mit einem anderen anti-krebs-mittel zu einer therapeutischen verwendung in der krebsbehandlung
|
US6649632B2
(en)
*
|
2000-02-02 |
2003-11-18 |
Fsu Research Foundation, Inc. |
C10 ester substituted taxanes
|
AR030188A1
(es)
*
|
2000-02-02 |
2003-08-13 |
Univ Florida State Res Found |
Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
|
CA2368151A1
(en)
*
|
2000-02-02 |
2001-08-09 |
Florida State University Research Foundation, Inc. |
C10 carbonate substituted taxanes as antitumor agents
|
JP2003522170A
(ja)
*
|
2000-02-02 |
2003-07-22 |
フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド |
抗腫瘍剤としてのc7カーボネート置換タキサン
|
PL202957B1
(pl)
*
|
2000-02-02 |
2009-08-31 |
Univ Florida State Res Found |
Podstawione grupą estrową C10 taksany, kompozycja farmaceutyczna zawierająca te związki i zastosowanie tych związków do wytwarzania leku
|
EP1265611A2
(en)
*
|
2000-02-29 |
2002-12-18 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with taxane compounds
|
US6362217B2
(en)
|
2000-03-17 |
2002-03-26 |
Bristol-Myers Squibb Company |
Taxane anticancer agents
|
US6638742B1
(en)
|
2000-07-07 |
2003-10-28 |
University Of Portland |
Methods for obtaining taxanes
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
HUP0302599A3
(en)
*
|
2000-09-22 |
2005-05-30 |
Bristol Myers Squibb Co |
Method for reducing toxicity of combined chemotherapic compositions
|
US6919370B2
(en)
*
|
2000-11-28 |
2005-07-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
KR20020066808A
(ko)
*
|
2001-02-14 |
2002-08-21 |
주식회사 삼양제넥스 |
비대칭 아미노히드록실레이션반응을 이용한 탁센 유도체의제조방법
|
CA2440935A1
(en)
|
2001-03-13 |
2002-09-19 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
US20020183266A1
(en)
|
2001-03-15 |
2002-12-05 |
Aventis Pharma, S.A. |
Combination comprising combretastatin and anticancer agents
|
US20020182204A1
(en)
*
|
2001-03-23 |
2002-12-05 |
Marie-Christine Bissery |
Combination of a taxane and a cyclin-dependent kinase
|
JP4634694B2
(ja)
*
|
2001-03-23 |
2011-02-16 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
脂肪アルコール薬物複合体
|
EP1427407A4
(en)
*
|
2001-03-23 |
2005-05-11 |
Luitpold Pharm Inc |
CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS
|
CA2444529C
(en)
*
|
2001-04-20 |
2010-11-23 |
The University Of British Columbia |
Micellar drug delivery systems for hydrophobic drugs
|
US6479679B1
(en)
|
2001-04-25 |
2002-11-12 |
Napro Biotherapeutics, Inc. |
Two-step conversion of protected taxane ester to paclitaxel
|
US6452025B1
(en)
|
2001-04-25 |
2002-09-17 |
Napro Biotherapeutics, Inc. |
Three-step conversion of protected taxane ester to paclitaxel
|
JP2005515187A
(ja)
*
|
2001-11-26 |
2005-05-26 |
スーパージェン インコーポレイテッド |
ポリオキシエチル化ひまし油を使用する医薬組成物の調製方法
|
WO2003045357A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
PL368945A1
(en)
*
|
2001-11-30 |
2005-04-04 |
Bristol-Myers Squibb Company |
Paclitaxel solvates
|
EP1465618A2
(en)
*
|
2001-12-20 |
2004-10-13 |
Bristol-Myers Squibb Company |
Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
|
US20030216758A1
(en)
*
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
CN1652845A
(zh)
|
2002-05-17 |
2005-08-10 |
安万特医药股份有限公司 |
多西他赛/阿霉素/环磷酰胺在辅助治疗乳腺癌和卵巢癌中的用途
|
ES2377318T3
(es)
|
2002-09-06 |
2012-03-26 |
Cerulean Pharma Inc. |
Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
|
US20080220074A1
(en)
*
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
AU2003273671A1
(en)
*
|
2002-10-09 |
2004-05-04 |
Phytogen Life Sciences, Inc. |
Novel taxanes and methods related to use and preparation thereof
|
WO2004060346A2
(en)
|
2002-12-30 |
2004-07-22 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
US8703982B2
(en)
|
2003-03-17 |
2014-04-22 |
Phyton Holdings Llc |
Purification of taxanes
|
CN1268619C
(zh)
*
|
2003-05-08 |
2006-08-09 |
上海迪赛诺化学制药有限公司 |
多烯紫杉醇三水化合物的制备方法
|
US7202370B2
(en)
*
|
2003-10-27 |
2007-04-10 |
Conor Medsystems, Inc. |
Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
|
US20060034943A1
(en)
*
|
2003-10-31 |
2006-02-16 |
Technology Innovations Llc |
Process for treating a biological organism
|
SV2006002010A
(es)
*
|
2004-02-13 |
2006-08-23 |
Univ Florida State Res Found |
Taxanos sustituidos con esteres de ciclopentilo en c10
|
GT200500025A
(es)
*
|
2004-02-13 |
2005-09-30 |
|
Taxanos sustituidos con esteres de ciclopentilo en c10
|
US20050192445A1
(en)
*
|
2004-03-01 |
2005-09-01 |
Phytogen Life Sciences Inc. |
Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel
|
US7846940B2
(en)
*
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
CN101146532B
(zh)
|
2005-01-21 |
2012-05-09 |
阿斯泰克斯治疗有限公司 |
药物化合物
|
EP1848423A4
(en)
*
|
2005-02-14 |
2008-12-31 |
Univ Florida State Res Found |
C10 CYCLOPROPYL ESTER SUBSTITUTED TAXAN COMPOSITIONS
|
CN1300131C
(zh)
*
|
2005-04-27 |
2007-02-14 |
浙江钱江生物化学股份有限公司 |
赤霉素ga3纯化分离方法
|
US9346029B2
(en)
|
2005-06-06 |
2016-05-24 |
The University Of British Columbia |
Polymer-based serum albumin substitute
|
JP2008543789A
(ja)
*
|
2005-06-17 |
2008-12-04 |
ホスピラ オーストラリア ピーティーワイ エルティーディー |
ドセタキセルの液体薬学的処方物
|
CN1314675C
(zh)
*
|
2005-07-01 |
2007-05-09 |
中国科学院上海有机化学研究所 |
紫杉醇衍生物
|
KR101457834B1
(ko)
*
|
2005-08-31 |
2014-11-05 |
아브락시스 바이오사이언스, 엘엘씨 |
증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조 방법
|
HUE048521T2
(hu)
|
2005-08-31 |
2020-08-28 |
Abraxis Bioscience Llc |
Gyengén vízoldékony gyógyszerészeti és antimikrobális hatóanyagokat tartalmazó keverékek
|
US20070073385A1
(en)
*
|
2005-09-20 |
2007-03-29 |
Cook Incorporated |
Eluting, implantable medical device
|
US20070196423A1
(en)
*
|
2005-11-21 |
2007-08-23 |
Med Institute, Inc. |
Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
|
AR054215A1
(es)
*
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
EP1998808A1
(en)
|
2006-02-21 |
2008-12-10 |
Dabur Pharma Limited |
Stable pharmaceutical composition of taxanes
|
WO2007103327A2
(en)
*
|
2006-03-06 |
2007-09-13 |
Acs Industries, Inc. |
Sliding sealing connector
|
KR101009467B1
(ko)
*
|
2006-03-13 |
2011-01-19 |
주식회사 셀트리온화학연구소 |
도세탁셀의 합성에 유용한 탁산 유도체 및 그 제조방법
|
JP2009533330A
(ja)
*
|
2006-03-21 |
2009-09-17 |
ドクター レディズ ラボラトリーズ リミテッド |
ドセタキセルの多形体およびプロセス
|
US20070231915A1
(en)
*
|
2006-03-29 |
2007-10-04 |
Cangen Biotechnologies, Inc. |
Apparatus and method for filtration to enhance the detection of peaks
|
US20070231917A1
(en)
*
|
2006-03-29 |
2007-10-04 |
Cangen Biotechnologies, Inc. |
Apparatus and method for filtration to enhance the detection of peaks
|
US20070231916A1
(en)
*
|
2006-03-29 |
2007-10-04 |
Cangen Biotechnologies, Inc. |
Apparatus and method for filtration to enhance the detection of peaks
|
WO2007126987A2
(en)
*
|
2006-03-29 |
2007-11-08 |
Cangen Biotechnologies, Inc. |
Methods of predicting response to a treatment for a disease
|
US20080046224A1
(en)
*
|
2006-03-29 |
2008-02-21 |
Cangen Biotechnologies, Inc. |
Apparatus and method for predicting disease
|
US20070238193A1
(en)
*
|
2006-03-29 |
2007-10-11 |
Cangen Biotechnologies, Inc. |
Apparatus and method for filtration to enhance the detection of peaks
|
CN100417649C
(zh)
*
|
2006-04-05 |
2008-09-10 |
云南思摩贝特生物科技有限公司 |
一种多西他赛的制备方法
|
PL217731B1
(pl)
|
2006-06-01 |
2014-08-29 |
Tomasz Byrski |
Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi
|
EP2380606B1
(en)
|
2006-06-30 |
2018-03-21 |
Cook Medical Technologies LLC |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
US7585865B2
(en)
*
|
2006-07-21 |
2009-09-08 |
The Penn State Research Foundation |
Protein kinase C zeta inhibition to treat vascular permeability
|
JP5571380B2
(ja)
*
|
2006-07-24 |
2014-08-13 |
ルミナス バイオサイエンシズ,インコーポレイテッド |
オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物
|
GEP20115218B
(en)
*
|
2006-10-06 |
2011-05-25 |
Takeda Pharmaceutical |
Combination drug
|
JP5528806B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
WO2008044045A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
EP2094084A4
(en)
*
|
2006-10-20 |
2010-01-13 |
Scinopharm Singapore Pte Ltd |
PROCESS FOR PREPARING CRYSTALLINE WATER-FREE DOCETAXEL
|
KR101541550B1
(ko)
|
2006-10-27 |
2015-08-04 |
제넨테크, 인크. |
항체 및 면역접합체 및 이들의 용도
|
EP2115173B1
(en)
|
2007-01-08 |
2011-09-21 |
Government of the USA, as Represented by the Secretary, Department of Health and Human Services |
Slco1b3 genotype
|
US20080176958A1
(en)
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
GB0701523D0
(en)
*
|
2007-01-26 |
2007-03-07 |
Chatham Biotec Ltd |
Semi-synthetic process for the preparation of taxane derivatives
|
WO2008102374A1
(en)
*
|
2007-02-20 |
2008-08-28 |
Dabur Pharma Limited |
Amorphous form of docetaxel
|
US20080241215A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Robert Falotico |
Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
|
EP2146695A4
(en)
*
|
2007-04-23 |
2010-05-19 |
Sun Pharmaceuticals Ind Ltd |
PHARMACEUTICAL COMPOSITIONS
|
KR20100023862A
(ko)
*
|
2007-06-22 |
2010-03-04 |
싸이도우스 엘엘씨. |
트윈 80을 함유하지 않은 도세탁셀의 용해 제제
|
EP2173732A4
(en)
*
|
2007-07-04 |
2011-09-07 |
Reddys Lab Ltd Dr |
PROCESSES FOR THE PREPARATION OF DOCETAXEL AND POLYMORPHIC
|
AR063111A1
(es)
*
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
EA034136B1
(ru)
|
2007-11-09 |
2020-01-09 |
Перигрин Фармасьютикалз, Инк. |
Изолированное антитело, которое связывается с vegf, и его применения
|
EA201000807A1
(ru)
|
2007-11-15 |
2011-02-28 |
Инститьют Оф Мэтэрия Медика, Чайниз |
Производные цефаломаннина, их приготовление, фармацевтические композиции и применение
|
AU2008352597B2
(en)
|
2008-03-14 |
2012-03-08 |
Bionumerik Pharmaceuticals, Inc. |
Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
|
WO2009113989A1
(en)
|
2008-03-14 |
2009-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Compositions and methods of use of compounds to increase cancer patient survival time
|
DK2644194T3
(en)
|
2008-03-18 |
2017-07-03 |
Genentech Inc |
Combinations of an anti-HER2 antibody-drug conjugate and docetaxel
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
CA2718567A1
(en)
*
|
2008-03-31 |
2009-12-03 |
Florida State University Research Foundation, Inc. |
C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes
|
EP2285792A2
(en)
*
|
2008-05-07 |
2011-02-23 |
Ivax Research, Llc |
Processes for preparation of taxanes and intermediates thereof
|
US8273404B2
(en)
*
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
US9447049B2
(en)
|
2010-03-01 |
2016-09-20 |
University Of Tennessee Research Foundation |
Compounds for treatment of cancer
|
CN102159250B
(zh)
|
2008-08-11 |
2014-08-06 |
尼克塔治疗公司 |
多臂的聚合烷酸酯偶联物
|
US8642063B2
(en)
*
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US9198968B2
(en)
|
2008-09-15 |
2015-12-01 |
The Spectranetics Corporation |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
US8541360B2
(en)
*
|
2008-11-19 |
2013-09-24 |
Ben Venue Laboratories, Inc. |
Parenteral formulations comprising sugar-based esters and ethers
|
KR20100060351A
(ko)
|
2008-11-27 |
2010-06-07 |
한국생명공학연구원 |
L1cam의 활성 또는 발현을 억제하는 물질 및 항암제를포함하는 항암용 조성물
|
FR2939665B1
(fr)
|
2008-12-12 |
2011-10-07 |
Sanofi Aventis |
Combinaison antitumorale associant l'ave8062a et le docetaxel
|
AU2009329872B2
(en)
|
2008-12-23 |
2016-07-07 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
KR20110098849A
(ko)
*
|
2008-12-23 |
2011-09-01 |
파마셋 인코포레이티드 |
뉴클레오시드 유사체
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
JP2012520314A
(ja)
|
2009-03-11 |
2012-09-06 |
アムビト ビオスシエンセス コルポラチオン |
癌治療のためのインダゾリルアミノピロロトリアジンとタキサンの併用
|
PL388144A1
(pl)
|
2009-05-29 |
2010-12-06 |
Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością |
Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
CA2779009A1
(en)
|
2009-10-29 |
2011-05-05 |
Aventis Pharma S.A. |
Novel antitumoral use of cabazitaxel
|
CN104208716A
(zh)
*
|
2009-11-23 |
2014-12-17 |
天蓝制药公司 |
用于传递治疗剂的基于环糊精的聚合物
|
WO2011069074A2
(en)
|
2009-12-04 |
2011-06-09 |
Genentech, Inc. |
Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1
|
KR20120111739A
(ko)
|
2009-12-31 |
2012-10-10 |
센트로 내셔널 드 인베스티가시오네스 온콜로지카스 (씨엔아이오) |
키나제 억제제로서의 사용을 위한 삼환식 화합물
|
CA2787714C
(en)
|
2010-01-22 |
2019-04-09 |
Joaquin Pastor Fernandez |
Inhibitors of pi3 kinase
|
WO2011101644A1
(en)
|
2010-02-18 |
2011-08-25 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Triazolo [4, 5 - b] pyridin derivatives
|
CA2791416C
(en)
|
2010-03-01 |
2018-05-15 |
The University Of British Columbia |
Derivatized hyperbranched polyglycerols
|
US11084811B2
(en)
|
2010-03-01 |
2021-08-10 |
Oncternal Therapeutics, Inc. |
Compounds for treatment of cancer
|
TW201139457A
(en)
|
2010-03-31 |
2011-11-16 |
Pharmasset Inc |
Stereoselective synthesis of phosphorus containing actives
|
WO2011121317A1
(en)
|
2010-04-01 |
2011-10-06 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazo [2,1-b] [1,3,4] thiadiazoles as protein or lipid kinase inhibitors
|
EA027666B1
(ru)
|
2010-05-03 |
2017-08-31 |
ТЕИКОКУ ФАРМА ЮСЭй, ИНК. |
Неводные лекарственные средства в форме проэмульсии на основе таксанов и способы их приготовления и использования
|
CN102296053B
(zh)
|
2010-06-25 |
2015-03-11 |
中国医学科学院药物研究所 |
一种7-木糖紫杉烷糖基水解酶、其基因的核苷酸序列及其应用
|
WO2012000118A1
(en)
|
2010-07-02 |
2012-01-05 |
Angiochem Inc. |
Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
|
WO2012052745A1
(en)
|
2010-10-21 |
2012-04-26 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Combinations of pi3k inhibitors with a second anti -tumor agent
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
WO2012088422A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
WO2012088433A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Deuterated and/or fluorinated taxane derivatives
|
FI2694072T4
(fi)
|
2011-04-01 |
2024-09-30 |
Genentech Inc |
Akt-inhibiittoriyhdisteen ja abirateronin yhdistelmä käytettäväksi terapeuttisissa hoidoissa
|
EP2697211A4
(en)
|
2011-04-01 |
2014-08-13 |
Shilpa Medicare Ltd |
PROCESS FOR THE PREPARATION OF DOCETAXEL AND ITS HYDRATE
|
ES2642170T3
(es)
|
2011-05-16 |
2017-11-15 |
Taiho Pharmaceutical Co., Ltd. |
Método para seleccionar la quimioterapia para un paciente con cáncer gástrico utilizando combinación de fármacos de tegafur, gimeracilo y oteracilo potásico e inhibidor de EGFR
|
US9284334B2
(en)
|
2011-05-19 |
2016-03-15 |
Fundación Centro Nacional De Investigaciones Oncologicas Carlos Iii |
Macrocyclic compounds as protein kinase inhibitors
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
WO2013004984A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Tricyclic compounds for use as kinase inhibitors
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
WO2013005041A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Tricyclic heterocyclic compounds as kinase inhibitors
|
WO2013036795A2
(en)
|
2011-09-08 |
2013-03-14 |
New York University |
Oncolytic herpes simplex virus and therapeutic uses thereof
|
KR102090740B1
(ko)
|
2011-10-03 |
2020-03-18 |
엠엑스 아쥬바크 에이비 |
암 치료 및 식품 관련 화합물을 포함하는 의학 분야에서 양친매성 또는 소수성 분자를 위한 나노입자, 제조 방법 및 담체로의 용도
|
CN102408397B
(zh)
|
2011-10-19 |
2014-08-20 |
上海贝美医药科技有限公司 |
紫杉烷类衍生物及其制备方法
|
WO2013096455A1
(en)
|
2011-12-20 |
2013-06-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
CA2874521A1
(en)
|
2012-05-24 |
2013-11-28 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
|
KR101689946B1
(ko)
|
2012-06-08 |
2016-12-26 |
에프. 호프만-라 로슈 아게 |
암의 치료를 위한 포스포이노시타이드 3 키나제 억제제 화합물 및 화학치료제의 돌연변이체 선택성 및 조합물
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
US20150285802A1
(en)
|
2012-07-18 |
2015-10-08 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
EP2964028A4
(en)
*
|
2013-03-05 |
2017-06-07 |
University of Tennessee Research Foundation |
Compounds for treatment of cancer
|
WO2014149871A1
(en)
|
2013-03-14 |
2014-09-25 |
Icahn School Of Medicine At Mount Sinai |
Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
|
US9907846B2
(en)
|
2013-04-01 |
2018-03-06 |
Mx Adjuvac Ab |
Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
|
SG11201509350RA
(en)
|
2013-06-11 |
2015-12-30 |
Bayer Pharma AG |
Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
|
US10130590B2
(en)
|
2013-10-01 |
2018-11-20 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
US9783547B2
(en)
|
2014-01-15 |
2017-10-10 |
Centre National De La Recherche Scientifique (Cnrs) |
Water soluble 4-azapodophyllotoxin analogs
|
TW202330606A
(zh)
|
2014-03-21 |
2023-08-01 |
美商艾伯維有限公司 |
抗-egfr抗體及抗體藥物結合物
|
US10350264B2
(en)
|
2014-03-27 |
2019-07-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
EP3307330B1
(en)
|
2015-06-15 |
2021-03-10 |
New York University |
Method of treatment using oncolytic viruses
|
JP6877049B2
(ja)
|
2015-09-25 |
2021-05-26 |
ゼットワイ セラピューティクス インク.Zy Therapeutics Inc. |
多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤
|
HUP1500603A2
(en)
*
|
2015-12-11 |
2017-06-28 |
Rotachrom Tech Kft |
Process for the separation of 10-deacetyl baccatin iii
|
MX2018011102A
(es)
|
2016-03-15 |
2019-01-10 |
Oryzon Genomics Sa |
Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos.
|
BR112018075649A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
anticorpos anti-b7-h3 e conjugados de fármaco de anticorpo
|
MX2018015277A
(es)
|
2016-06-08 |
2019-09-06 |
Abbvie Inc |
Anticuerpos anti-b7-h3 y conjugados de anticuerpo y farmaco.
|
IL300274A
(en)
|
2016-06-08 |
2023-04-01 |
Abbvie Inc |
Antibodies against B7–H3 and conjugates of drug and antibody
|
EP3468599A2
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
MX2018015274A
(es)
|
2016-06-08 |
2019-10-07 |
Abbvie Inc |
Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
|
PL3532059T3
(pl)
|
2016-10-27 |
2022-05-09 |
Celgene Quanticel Research, Inc. |
Terapia skojarzona z zastosowaniem inhibitora białka bet
|
WO2018094275A1
(en)
|
2016-11-18 |
2018-05-24 |
Tolero Pharmaceuticals, Inc. |
Alvocidib prodrugs and their use as protein kinase inhibitors
|
JP7247101B2
(ja)
|
2017-04-03 |
2023-03-28 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
Steap-1に結合する抗体
|
US11497756B2
(en)
|
2017-09-12 |
2022-11-15 |
Sumitomo Pharma Oncology, Inc. |
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
|
WO2019178438A1
(en)
|
2018-03-15 |
2019-09-19 |
Abbvie Inc. |
Abbv-621 in combination with anti-cancer agents for the treatment of cancer
|
WO2019178433A1
(en)
|
2018-03-15 |
2019-09-19 |
Abbvie Inc. |
Abbv-621 in combination with anti-cancer agents for the treatment of pancreatic cancer
|
JP2022511029A
(ja)
|
2018-12-04 |
2022-01-28 |
スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド |
がんの処置のための薬剤としての使用のためのcdk9インヒビターおよびその多形
|
EP3669890A1
(en)
|
2018-12-18 |
2020-06-24 |
Croda International PLC |
Filamentous nanoparticles having vaccine adjuvant effect
|
US11793802B2
(en)
|
2019-03-20 |
2023-10-24 |
Sumitomo Pharma Oncology, Inc. |
Treatment of acute myeloid leukemia (AML) with venetoclax failure
|
CN114080225A
(zh)
|
2019-08-08 |
2022-02-22 |
来凯有限公司 |
治疗癌症的方法
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|